Med Communications is attending the DIA 2026 Global Annual Meeting in Philadelphia, PA, this week. This meeting brings together leaders across the life sciences and regulatory space, and we are…
Med Communications will be attending the DIA 2026 Global Annual Meeting in Philadelphia, PA, June 14–18, 2026. We’ll be joining more than 4,000 life sciences professionals, regulatory experts, and patient…
Look for us at the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, May 29-June 2. Med Communications’ Director, Scientific Communications and Medical/Promotional Review Liza Rinehart and Business…
Med Communications will be attending the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, May 29-June 2. More information about the meeting is available on the ASCO Annual…
Business Development Lead Stacy Witham and Principal Scientific Communications Manager Tiago Silva will be attending the International Society of Medical Publications Professionals (ISMPP) meeting April 20-22 in Washington, D.C. If…
We’re in Denver at the MAPS 2026 Annual Americas Meeting this week, Booth 116. Business Development Representative Natalie McClendon, Business Development Lead Jill Kembel, Director Scientific Communications and Medical/Promotional Review…
Join us in Denver at the MAPS 2026 Annual Americas Meeting, March 22-25. More meeting information is available here: https://s7.goeshow.com/maps/global/2026/. Hope to see you there!
Med Communications’ Global Head of Pharmacovigilance Maria Anitan, Business Development Lead Stacy Witham, and Business Development Representative Natalie McClendon will be attending the DIA Global Pharmacovigilance and Risk Management Strategies…
Med Communications’ Ann Winter-Vann, director of Regulatory Writing, and Jill Kembel, Business Development Lead, are at the AMWA conference in Phoenix, Arizona, this week. Ann is presenting a sold-out workshop…
Med Communications is at the World Drug Safety Congress Americas in Boston this week. Our Global Head of Pharmacovigilance and Drug Safety, Dr. Maria Anitan, will be participating in a…
